menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Changing Fibroid Treatment Protocols: Reactions to FDA Warnings on Power Morcellation

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    The "FDA Jury" is out on treatment for uterine fibroids, and it’s not favorable to the practice of laparoscopic power morcellation. That update, and more importantly an expert practitioner’s perspectives on the FDA's suggested recommendations, is the focus of this interview. Joining Dr. Matt Birnholz to discuss the current landscape in uterine fibroid treatments, and the changing perceptions on power morcellation procedures, is Dr. Michael Randell, practicing OB/GYN in the Department of Obstetrics and Gynecology at Northside Hospital in Atlanta, GA. Dr. Randell is a Diplomat of the American Board of Obstetrics and Gynecology and the National Board of Medical Examiners.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    The "FDA Jury" is out on treatment for uterine fibroids, and it’s not favorable to the practice of laparoscopic power morcellation. That update, and more importantly an expert practitioner’s perspectives on the FDA's suggested recommendations, is the focus of this interview. Joining Dr. Matt Birnholz to discuss the current landscape in uterine fibroid treatments, and the changing perceptions on power morcellation procedures, is Dr. Michael Randell, practicing OB/GYN in the Department of Obstetrics and Gynecology at Northside Hospital in Atlanta, GA. Dr. Randell is a Diplomat of the American Board of Obstetrics and Gynecology and the National Board of Medical Examiners.

Facebook Comments

Schedule28 Mar 2024